Literature DB >> 31077034

Neurocognitive Impairment in mdx Mice.

Clarissa M Comim1, Letícia Ventura2, Viviane Freiberger2, Paula Dias2, Daiane Bragagnolo2, Matheus L Dutra2, Ricardo A Amaral2, Ana Lucia S Camargo-Fagundes3, Patrícia A Reis4, Hugo C Castro-Faria-Neto4, Mariz Vainzof5, Maria I Rosa3.   

Abstract

Duchenne muscular dystrophy (DMD) is a neuromuscular disorder that affects muscles and also the brain, resulting in memory and behavioral problems. In the pathogenesis of DMD, inflammation is an important factor during the degenerative process. However, the involvement of the brain is still unclear. Therefore, the objective of this study is to evaluate the cognitive involvement, BDNF levels, cytokine levels through the levels of TNF-α and IL-1β, the myeloperoxidase (MPO) activity, and the expression of proteins postsynaptic density (PSD)-95 and synaptophysin in the brain of mdx mice. To this aim, we used adult mdx mice. It was observed that mdx mice presented deficits on the habituation, aversive, and object recognition memory. These animals also had a depression-like behavior and an anxiety-like behavior, a decrease of BDNF levels, an increase in the levels of TNF-α and IL-1β, an increase of MPO activity, and an overexpression of synaptophysin and PSD-95 in brain tissue. In conclusion, these data show that mdx mice possibly present a neuroinflammatory component and the involvement of synaptic proteins associated to memory storage and restoring process impairment as well as a depressive- and anxiety-like behavior.

Entities:  

Keywords:  Cognition; Duchenne muscular dystrophy; Inflammation; Memory and learning; mdx mice

Mesh:

Substances:

Year:  2019        PMID: 31077034     DOI: 10.1007/s12035-019-1573-7

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  51 in total

1.  Mitochondrial respiratory chain and creatine kinase activities in mdx mouse brain.

Authors:  Lisiane Tuon; Clarissa M Comim; Daine B Fraga; Giselli Scaini; Gislaine T Rezin; Bruna R Baptista; Emilio L Streck; Mariz Vainzof; João Quevedo
Journal:  Muscle Nerve       Date:  2010-02       Impact factor: 3.217

2.  Role of disease severity, illness perceptions, and mood on quality of life in muscle disease.

Authors:  Michael R Rose; Reza Sadjadi; John Weinman; Tayyaba Akhtar; Shree Pandya; John T Kissel; Carlayne E Jackson
Journal:  Muscle Nerve       Date:  2012-09       Impact factor: 3.217

3.  Animal model of depression.

Authors:  R D Porsolt
Journal:  Biomedicine       Date:  1979-07

Review 4.  Neuropsychological and neurobehavioral functioning in Duchenne muscular dystrophy: a review.

Authors:  Wanda M Snow; Judy E Anderson; Lorna S Jakobson
Journal:  Neurosci Biobehav Rev       Date:  2013-03-29       Impact factor: 8.989

5.  Prevalence of fatigue, pain, and affective disorders in adults with duchenne muscular dystrophy and their associations with quality of life.

Authors:  Robert F Pangalila; Geertrudis A van den Bos; Bart Bartels; Michael Bergen; Henk J Stam; Marij E Roebroeck
Journal:  Arch Phys Med Rehabil       Date:  2015-02-27       Impact factor: 3.966

Review 6.  Cognitive dysfunction in Duchenne muscular dystrophy: a possible role for neuromodulatory immune molecules.

Authors:  Mark G Rae; Dervla O'Malley
Journal:  J Neurophysiol       Date:  2016-07-06       Impact factor: 2.714

7.  Expression of tumor necrosis factor-alpha in regenerating muscle fibers in inflammatory and non-inflammatory myopathies.

Authors:  Satoshi Kuru; Akira Inukai; Takashi Kato; Yideng Liang; Seigo Kimura; Gen Sobue
Journal:  Acta Neuropathol       Date:  2002-11-22       Impact factor: 17.088

8.  Striatum brain-derived neurotrophic factor levels are decreased in dystrophin-deficient mice.

Authors:  Clarissa M Comim; Lisiane Tuon; Laura Stertz; Mariz Vainzof; Flávio Kapczinski; João Quevedo
Journal:  Neurosci Lett       Date:  2009-05-05       Impact factor: 3.046

9.  Psychopathological assessment in children affected by Duchenne de Boulogne muscular dystrophy.

Authors:  M Roccella; R Pace; M T De Gregorio
Journal:  Minerva Pediatr       Date:  2003-06       Impact factor: 1.312

10.  Influence of full-length dystrophin on brain volumes in mouse models of Duchenne muscular dystrophy.

Authors:  Bauke Kogelman; Artem Khmelinskii; Ingrid Verhaart; Laura van Vliet; Diewertje I Bink; Annemieke Aartsma-Rus; Maaike van Putten; Louise van der Weerd
Journal:  PLoS One       Date:  2018-03-30       Impact factor: 3.240

View more
  3 in total

1.  Characterization of brain dystrophins absence and impact in dystrophin-deficient Dmdmdx rat model.

Authors:  Dorian Caudal; Virginie François; Aude Lafoux; Mireille Ledevin; Ignacio Anegon; Caroline Le Guiner; Thibaut Larcher; Corinne Huchet
Journal:  PLoS One       Date:  2020-03-11       Impact factor: 3.240

2.  Assessment of Behavioral Characteristics With Procedures of Minimal Human Interference in the mdx Mouse Model for Duchenne Muscular Dystrophy.

Authors:  Sarah Engelbeen; Annemieke Aartsma-Rus; Bastijn Koopmans; Maarten Loos; Maaike van Putten
Journal:  Front Behav Neurosci       Date:  2021-01-20       Impact factor: 3.558

3.  Characterization of Alzheimer's disease-like neuropathology in Duchenne's muscular dystrophy using the DBA/2J mdx mouse model.

Authors:  Grant C Hayward; Daniela Caceres; Emily N Copeland; Bradley J Baranowski; Ahmad Mohammad; Kennedy C Whitley; Val A Fajardo; Rebecca E K MacPherson
Journal:  FEBS Open Bio       Date:  2021-11-11       Impact factor: 2.693

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.